Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
29.05. | Earnings call: MediWound reports a revenue increase to $5 million in Q1 | 1 | Investing.com | ||
29.05. | MediWound GAAP EPS of -$1.05 misses by $0.64, revenue of $4.96M beats by $0.29M | 1 | Seeking Alpha | ||
29.05. | MediWound Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
29.05. | MediWound Ltd.: MediWound Reports First Quarter 2024 Financial Results and Provides Company Update | 121 | GlobeNewswire (Europe) | NexoBrid® interest surges; $5 million in Q1 2024 revenue, with $24 million forecast for the year Manufacturing facility on target for completion by mid-2024 EscharEx® Phase III study to launch 2H... ► Artikel lesen | |
28.05. | MediWound Q1 2024 Earnings Preview | 1 | Seeking Alpha | ||
22.05. | MediWound Ltd.: MediWound to Report First Quarter 2024 Financial Results | 2 | GlobeNewswire (USA) | ||
22.03. | Earnings call: MediWound forecasts growth with NexoBrid and EscharEx advances | 1 | Investing.com | ||
21.03. | MediWound Ltd. - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
21.03. | MediWound reports mixed Q4 results; initiates FY24 outlook | 1 | Seeking Alpha | ||
21.03. | MediWound Ltd.: MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update | 139 | GlobeNewswire (Europe) | $19 million revenue in 2023; $24 million projected revenue in 2024NexoBrid® commercially launched in U.S., Japan, IndiaPotential blockbuster EscharEx® to begin Phase III in the second half of 2024$42... ► Artikel lesen | |
21.03. | MediWound Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
20.03. | Preview: MediWound's Earnings | 1 | Benzinga.com | ||
20.03. | MediWound Q4 2023 Earnings Preview | 1 | Seeking Alpha | ||
12.02. | MediWound stock climbs 9% on Phase 2 data for wound care treatment | 2 | Seeking Alpha | ||
12.02. | MediWound Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
05.02. | MediWound Ltd.: MediWound to Participate in Two Upcoming Investor Conferences | 1 | GlobeNewswire (USA) | ||
09.01. | FDA accepts MediWound application for NexoBrid pediatric approval | 1 | Seeking Alpha | ||
09.01. | MediWound: FDA To Review NexoBrid SBLA For Removal Of Eschar In Pediatric Patients | 2 | RTTNews | ||
08.01. | MediWound Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
29.12.23 | MediWound Receives $6.7 Million U.S. DoD Funding For Advancing NexoBrid Development | 3 | pulse2.com |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 2.546 |
NVIDIA | 1.815 |
TUI | 1.559 |
BAYER | 1.147 |
NEL | 1.137 |
GAMESTOP | 1.088 |
RHEINMETALL | 1.012 |
BYD | 881 |
DEUTSCHE LUFTHANSA | 775 |
VOLKSWAGEN | 561 |
SNOWFLAKE | 471 |
TESLA | 471 |
BASF | 445 |
THYSSENKRUPP | 442 |
AIXTRON SE | 399 |
COMMERZBANK | 390 |
PORSCHE SE | 388 |
APPLE | 367 |
MERCEDES-BENZ | 355 |
DEFI TECHNOLOGIES | 354 |
ALLIANZ | 349 |
CAVENDISH HYDROGEN | 347 |
DEUTSCHE BANK | 346 |
RWE | 334 |
THYSSENKRUPP NUCERA | 314 |